Inhibitory activities of Lignum Sappan extractives on growth and growth-related signaling of tumor cells

Sasaki, 2007, In vitro study for inhibition of NO production about constituents of Sappan Lignum [J], Biol Pharm Bull, 30, 193, 10.1248/bpb.30.193 Washiyama, 2009, Anti-inflammatory constituents of Sappan Lignum [J], Biol Pharm Bull, 32, 941, 10.1248/bpb.32.941 Yodsaoue, 2009, Anti-allergic activity of principles from the roots and heartwood of Caesalpinia sappan on antigen-induced beta-hexosaminidase release [J], Phytother Res, 23, 1028, 10.1002/ptr.2670 Niranjan Reddy, 2003, Inhibitory activity of homoisoflavonoids from Caesalpinia sappan against Beauveria bassiana [J], Fitoterapia, 74, 600, 10.1016/S0367-326X(03)00153-9 Liu, 2009, In vitro anti-influenza viral activities of constituents from Caesalpinia sappan [J], Planta Med, 75, 337, 10.1055/s-0028-1112208 Badami, 2003, Antioxidant activity of Caesalpinia sappan heartwood [J], Biol Pharm Bull, 26, 1534, 10.1248/bpb.26.1534 Lee, 2010, Antioxidant properties of benzylchroman derivatives from Caesalpinia sappan L. against oxidative stress evaluated in vitro [J], J Enzyme Inhib Med Chem, 25, 608, 10.3109/14756360903373376 Sasaki, 2010, Vasorelaxant activity of Sappan Lignum constituents and extracts on rat aorta and mesenteric artery [J], Biol Pharm Bull, 33, 1555, 10.1248/bpb.33.1555 Kim, 2005, Caesalpinia sappan induces cell death by increasing the expression of p53 and p21WAF1/CIP1 in head and neck cancer cells [J], Am J Chin Med, 33, 405, 10.1142/S0192415X05003016 Lee, 2010, Isoliquiritigenin 2′-methyl ether induces growth inhibition and apoptosis in oral cancer cells via heme oxygenase-1 [J], Toxicol In Vitro, 24, 776, 10.1016/j.tiv.2009.12.024 Grivennikov, 2010, Inflammation and oncogenesis: a vicious connection [J], Curr Opin Genet Dev, 20, 65, 10.1016/j.gde.2009.11.004 Reuter, 2010, Oxidative stress, inflammation, and cancer: how are they linked? [J], Free Radic Biol Med, 49, 1603, 10.1016/j.freeradbiomed.2010.09.006 Wu, 2009, Inflammation: a driving force speeds cancer metastasis [J], Cell Cycle, 8, 3267, 10.4161/cc.8.20.9699 Grivennikov, 2010, Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer [J], Cytokine Growth Factor Rev, 21, 11, 10.1016/j.cytogfr.2009.11.005 Pensa, 2009, Stat3 and the inflammation/acute phase response in involution and breast cancer [J], J Mammary Gland Biol Neoplasia, 14, 121, 10.1007/s10911-009-9124-x Aggarwal, 2009, Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe [J], Clin Cancer Res, 15, 425, 10.1158/1078-0432.CCR-08-0149 Bollrath, 2009, IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis [J], EMBO Rep, 10, 1314, 10.1038/embor.2009.243 Namikoshi, 1987, Homoisoflavonoids and related compounds III. Phenolic constituents of Caesalpinia japonica Sieb. et Zucc [J], Chem Pharm Bull, 35, 3568, 10.1248/cpb.35.3568 Nguyen, 2005, Xanthine oxidase inhibitors from the heartwood of Vietnamese Caesalpinia sappan [J], Chem Pharm Bull (Tokyo), 53, 984, 10.1248/cpb.53.984 Chen, 2008, Chemical constituents from Sappan Lignum [J], J Chin Pharm Sci, 17, 82 Nagai, 1984, Sappanchalcone from Caesalpinia sappan L., the proposed biosynthetic precursor of brazilin [J], Yakugaku Zasshi, 104, 935, 10.1248/yakushi1947.104.9_935 Bae, 2005, Suppression of lipopolysaccharide-induced expression of inducible nitric oxide synthase by brazilin in RAW 264.7 macrophage cells [J], Eur J Pharmacol, 513, 237, 10.1016/j.ejphar.2005.03.011 Yadav, 2011, The role of chalcones in suppression of NF-κB-mediated inflammation and cancer [J], Int Immunopharmacol, 11, 295, 10.1016/j.intimp.2010.12.006 Rajendran, 2011, Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo [J], Clin Cancer Res, 17, 1425, 10.1158/1078-0432.CCR-10-1123 Bromberg, 1999, Stat3 as an oncogene [J], Cell, 98, 295, 10.1016/S0092-8674(00)81959-5 Devarajan, 2009, STAT3 as a central regulator of tumor metastases [J], Curr Mol Med, 9, 626, 10.2174/156652409788488720 Wu, 2010, TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion [J], Br J Cancer, 102, 639, 10.1038/sj.bjc.6605530 Wang, 2009, NF-kappaB signaling pathway, inflammation and colorectal cancer [J], Cell Mol Immunol, 6, 327, 10.1038/cmi.2009.43 Baud, 2009, Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls [J], Nat Rev Drug Discov, 8, 33, 10.1038/nrd2781 Tas, 2009, Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer [J], Curr Gene Ther, 9, 160, 10.2174/156652309788488569 Lin, 2010, The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy [J], Expert Opin Ther Targets, 14, 45, 10.1517/14728220903431069 Turkson, 2004, STAT proteins as novel targets for cancer drug discovery [J], Expert Opin Ther Targets, 8, 409, 10.1517/14728222.8.5.409